A brighter future for infertility treatment: study

December 5, 2011 in Genetics
A brighter future for infertility treatment: study

The various stages of sperm cell development.

(Medical Xpress) -- Male infertility could soon have a boost through new treatments at a sub-DNA 'epigenetic' level, according to researchers from The Australian National University.

The research team, led by Professor David Tremethick of The John Curtin School of Medical Research at ANU, have uncovered a new mechanism of gene activation which will have important implications in understanding how cellular differentiation is achieved. In the future, it may also allow the development of new approaches to treat . Their research is published in the latest issue of .

The team which included post-doctoral researchers Tanya Soboleva and Maxim Nekrasov made the breakthrough by looking at what’s happening in our bodies at the epigenetic level, which controls how our DNA is expressed.

“Epigenetic information goes beyond DNA-stored information essential for interpreting our genome,” said Professor Tremethick. “There are over 250 different cell types in the human body, and while the DNA sequence of these is essentially the same, their epigenetic information or profiles are very different. Additionally, our entire is compacted into a structure known as chromatin.

“Epigenetic information controls gene expression, ensuring that only genes for a specific cell type are turned on, while inappropriate genes are switched off by ‘opening’ or ‘closing’ the structure of chromatin.

“Regulation of this epigenetic information significantly contributes to embryonic development, and ensures our capacity to reproduce. Mis-regulation of our epigenetic code has been directly implicated in many common human diseases, as well as contributing to human infertility,” he said.

The research team’s study characterized the epigenetic changes that occur during sperm development, and in doing so identified a novel epigenetic mark, called H2A.Lap1.

“Our research revealed that H2A.Lap1 regulates sperm gene expression by directly opening the chromatin structure at the start site of active genes,” said Professor Tremethick.

“The study has therefore uncovered a new way to activate , which could help us understand how is achieved. In the future, this could also allow for the development of treatments for male which operate at the epigenetic level.”

Provided by Australian National University

5 /5 (2 votes)  

Rank 5 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

Uncovered: Genetic cause of complex disease seen in Irish Traveller community

Two independent groups of researchers — one led by Adrian Clark, at Queen Mary University of London, United Kingdom; and the other led by Jean-Laurent Casanova, at The Rockefeller University, New York — have now ...

Genetics created 14 hours ago | popularity 5 / 5 (2) | comments 0

Unraveling why children with Down syndrome have increased leukemia risk

Children with Down syndrome (DS) have an increased risk of developing leukemia, in particular acute megakaryoblastic leukemia (AMKL) and acute lymphoblastic leukemia (ALL). Through their studies in a mouse model of DS, a ...

Genetics created 14 hours ago | popularity 5 / 5 (1) | comments 0

Exposure to micronutrients pre-pregnancy associated with gene modifications in offspring

The offspring of women who were given micronutrient supplements (minerals needed in small quantities, such as iron, iodine and vitamin A) before they became pregnant had gene modifications at birth as well as when they were ...

Genetics created 15 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

New book ponders ethical issues of genetic testing

A patient who tested positive for the gene that leads to Huntington’s disease wrestled with a host of questions. Should she have children with her husband, knowing that each baby has a 50-50 chance of inheriting the ...

Genetics created 18 hours ago | popularity 5 / 5 (1) | comments 0

Specially-bred mice help target an annual outbreak: the flu

As part of a national collaboration, Oregon Health & Science University researchers are studying specially bred mice that are more like humans than ever before when it comes to genetic variation. Through these mice, the researchers ...

Genetics created Feb 21, 2012 | popularity 5 / 5 (1) | comments 0


Mini molecules could help fight battle of aortic bulge

When aortic walls buckle, the body's main blood pipe forms an ever-growing bulge. To thwart a deadly rupture, a team of Stanford University School of Medicine researchers has found two tiny molecules that may be able to orchestrate ...

Research links circadian rhythms to sudden cardiac death

A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body's natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or abn ...

Analysis of mTOR shows how the protein works, how new generation of drugs may defeat it

Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered ...

CT colonography shown to be comparable to standard colonoscopy

Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according ...

Phobia's effect on perception of feared object allows fear to persist

The more afraid a person is of a spider, the bigger that individual perceives the spider to be, new research suggests.

New melanoma drug Zelboraf nearly doubles survival in majority of patients

Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.